Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference By: Simulations Plus, Inc. via Business Wire February 28, 2023 at 08:30 AM EST Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at the Raymond James & Associates’ 44th Annual Institutional Investors Conference, scheduled for March 5-8, 2023, at the JW Marriott Grande Lakes in Orlando, Florida. Shawn O’Connor, chief executive officer, will present on Tuesday, March 7, 2023, at 1:40 p.m. Eastern Time. In addition, Mr. O’Connor will be available to host one-on-one meetings throughout the day. The live webcast and slide presentation will be available via this link and on the Investors page of the Simulations Plus website where it will also be available for replay after the event. The conference is by invitation only, so to attend the conference or request a one-on-one meeting, please contact your Raymond James representative. For more information about the Raymond James Institutional Investors Conference, please visit the Raymond James website or contact Brian Siegel from Hayden IR at brian@haydenir.com. About Simulations Plus Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005697/en/Contacts Simulations Plus Investor Relations Ms. Renee Bouche 661-723-7723 renee.bouche@simulations-plus.com Hayden IR Mr. Brian Siegel (346) 396-8696 brian@haydenir.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference By: Simulations Plus, Inc. via Business Wire February 28, 2023 at 08:30 AM EST Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at the Raymond James & Associates’ 44th Annual Institutional Investors Conference, scheduled for March 5-8, 2023, at the JW Marriott Grande Lakes in Orlando, Florida. Shawn O’Connor, chief executive officer, will present on Tuesday, March 7, 2023, at 1:40 p.m. Eastern Time. In addition, Mr. O’Connor will be available to host one-on-one meetings throughout the day. The live webcast and slide presentation will be available via this link and on the Investors page of the Simulations Plus website where it will also be available for replay after the event. The conference is by invitation only, so to attend the conference or request a one-on-one meeting, please contact your Raymond James representative. For more information about the Raymond James Institutional Investors Conference, please visit the Raymond James website or contact Brian Siegel from Hayden IR at brian@haydenir.com. About Simulations Plus Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005697/en/Contacts Simulations Plus Investor Relations Ms. Renee Bouche 661-723-7723 renee.bouche@simulations-plus.com Hayden IR Mr. Brian Siegel (346) 396-8696 brian@haydenir.com
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at the Raymond James & Associates’ 44th Annual Institutional Investors Conference, scheduled for March 5-8, 2023, at the JW Marriott Grande Lakes in Orlando, Florida. Shawn O’Connor, chief executive officer, will present on Tuesday, March 7, 2023, at 1:40 p.m. Eastern Time. In addition, Mr. O’Connor will be available to host one-on-one meetings throughout the day. The live webcast and slide presentation will be available via this link and on the Investors page of the Simulations Plus website where it will also be available for replay after the event. The conference is by invitation only, so to attend the conference or request a one-on-one meeting, please contact your Raymond James representative. For more information about the Raymond James Institutional Investors Conference, please visit the Raymond James website or contact Brian Siegel from Hayden IR at brian@haydenir.com. About Simulations Plus Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn. Environmental, Social, and Governance (ESG) We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005697/en/
Simulations Plus Investor Relations Ms. Renee Bouche 661-723-7723 renee.bouche@simulations-plus.com Hayden IR Mr. Brian Siegel (346) 396-8696 brian@haydenir.com
